CNS Neuroscience & Therapeutics is a peer-reviewed english-language open-access journal published by Wiley in China, operating under an open-access model since 2019. The journal covers Therapeutics. Pharmacology and Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry.
Authors are required to pay an article processing charge to publish in CNS Neuroscience & Therapeutics; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, CNS Neuroscience & Therapeutics has published 4,006 articles. Articles are minted with DOIs through the prefix 10.1111. All submissions undergo plagiarism screening before peer review.
Keywords
neuroscience, neurology, central nervous system, pharmacology, degenerative diseases, pharmacokinetics
At a glance
- Publisher
- Wiley
- Country
- China
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2019
- Review time
- 14 weeks
- DOI prefix
10.1111- Plagiarism check
- Yes
ISSN
- 1755-5930
- electronic
- 1755-5949
Frequently asked questions
Is CNS Neuroscience & Therapeutics peer-reviewed?
Does CNS Neuroscience & Therapeutics charge an article processing charge (APC)?
What subjects does CNS Neuroscience & Therapeutics publish?
What languages does CNS Neuroscience & Therapeutics accept?
What is the ISSN of CNS Neuroscience & Therapeutics?
1755-5930 (print) · 1755-5949 (electronic).